Methylene blue inhibits replication of SARS-CoV-2 in vitro

In December 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus diseases 2019 (COVID-19) emerged in Wuhan, China. Currently there is no antiviral treatment recommended against SARS-CoV-2. Identifying effective antiviral drugs is urgently requi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Antimicrob Agents
Glavni autori: Gendrot, Mathieu, Andreani, Julien, Duflot, Isabelle, Boxberger, Manon, Le Bideau, Marion, Mosnier, Joel, Jardot, Priscilla, Fonta, Isabelle, Rolland, Clara, Bogreau, Hervé, Hutter, Sébastien, La Scola, Bernard, Pradines, Bruno
Format: Artigo
Jezik:Inglês
Izdano: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7566888/
https://ncbi.nlm.nih.gov/pubmed/33075512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.106202
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items